Related Experiment Video
Updated: Aug 11, 2025

07:24
Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
6.5K
Noncoding RNAs in the crosstalk between multiple myeloma cells and bone marrow microenvironment
Wenjiao Tang1, Juan Xu1, Caigang Xu1
1Department of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Cancer Letters
|February 4, 2023
Summary
Multiple myeloma, a common blood cancer, remains incurable. This review explores how noncoding RNAs regulate the bone marrow microenvironment, offering new therapeutic strategies for this hematological malignancy.
Area of Science:
- Hematological Malignancies
- Cancer Biology
- Molecular Oncology
Background:
- Multiple myeloma (MM) is the second most prevalent hematological malignancy, characterized by its incurability and poorly understood pathogenesis and drug resistance mechanisms.
- The bone marrow microenvironment is critical in MM, influencing immune responses, drug resistance, and tumor progression, making it a key therapeutic target.
- Intercellular communication within the microenvironment is increasingly recognized as vital, with noncoding RNAs playing a significant regulatory role.
Approach:
- This review synthesizes current research on noncoding RNAs (ncRNAs) in the context of the MM bone marrow microenvironment.
- It examines the diverse roles of various ncRNA types, including microRNAs, long noncoding RNAs, circular RNAs, and PIWI-interacting RNAs.
- The focus is on how these ncRNAs mediate interactions between myeloma cells and the microenvironment.
Key Points:
- Noncoding RNAs are crucial regulators of cell-to-cell communication within the bone marrow microenvironment in multiple myeloma.
- Specific ncRNAs are implicated in key MM processes such as tumor cell growth, survival, migration, invasion, and the development of drug resistance.
- Understanding these ncRNA-mediated interactions is essential for deciphering MM pathogenesis and resistance.
Conclusions:
- Noncoding RNAs represent a significant area of study for understanding the complex biology of multiple myeloma.
- The regulatory functions of ncRNAs in the MM bone marrow microenvironment highlight their potential as novel therapeutic targets.
- Targeting ncRNAs offers promising avenues for developing more effective treatments for this challenging hematological malignancy.
Related Concept Videos
lncRNA - Long Non-coding RNAs
8.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Differentiation of Common Myeloid Progenitor Cells
3.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K

